SCHEMBL29925527

SCHEMBL29925527

C1=C(c2ccc(C3CCCN3)cc2)N(CCCN2CCCCC2)[C@H]2Sc3ccccc3N12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 4/20 0.33
▸ AKT1 P31749 1/20 0.32
▸ FPR2 P25090 2/20 0.32
▸ KCNH2 Q12809 5/20 0.31
▸ HRH3 Q9Y5N1 4/20 0.31
▸ ADRA1D P25100 2/20 0.31
▸ LMNA P02545 1/20 0.30
▸ PGR P06401 1/20 0.30
▸ CHRM2 P08172 1/20 0.30
▸ HTR1A P08908 1/20 0.30
▸ ADRA2A P08913 1/20 0.30
▸ CHRM1 P11229 1/20 0.30
▸ DRD1 P21728 1/20 0.30
▸ TBXA2R P21731 1/20 0.30
▸ ACHE P22303 1/20 0.30
▸ PTGS1 P23219 1/20 0.30
▸ SLC6A2 P23975 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ SLC6A4 P31645 1/20 0.30
▸ ADRA1A P35348 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29925414 0.88 FPR2 (0.34) KDM1AFPR2KCNH2LMNAPGR
SCHEMBL29924718 0.88 FPR2 (0.34) KDM1AFPR2KCNH2LMNAPGR
SCHEMBL30085699 0.85 HRH3 (0.39) KDM1AFPR2KCNH2HRH3LMNA
SCHEMBL29924842 0.84 CACNA1C (0.32) AKT1MKNK1
SCHEMBL29925052 0.84 CACNA1C (0.32) AKT1MKNK1
SCHEMBL30085708 0.83 HRH3 (0.37) KDM1AFPR2KCNH2HRH3ADRA1D
SCHEMBL30085724 0.81 HRH3 (0.36) KDM1AFPR2HRH3
SCHEMBL30085768 0.76 KDM4E (0.38) KDM1AFPR2KCNH2HRH3ACHE
SCHEMBL29924781 0.75 FPR2 (0.34) KDM1AFPR2KCNH2HRH3ACHE
SCHEMBL29924699 0.75 FPR2 (0.34) KDM1AFPR2KCNH2ADRA1DLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4274569-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER Anima Biotech Inc. (US) 2023-11-15 — — EP disclosed
WO-2022150316-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC. (US) 2022-07-14 — — WO disclosed
Send feedback